Research

Where You Are:

Moffitt Cancer Center is one of 41 NCI-designated comprehensive cancer centers in the country and the only one based in Florida. The designation is bestowed upon institutions that have significant peer-reviewed research funding; high-quality programs in basic, translational and population research; are dedicated to developing more effective approaches to cancer prevention, diagnosis and therapy; educate health care professionals and the public; and reach out to underserved populations.

Moffitt's impact on cancer research spans basic science, prevention and clinical research with a focus on translating discoveries into better care.

Research Disciplines | Clinical Trials | Research Cores & Technology | Find a Researcher  | Conflict of Interest


Moffitt Research News

Moffitt Cancer Center Researchers Find Loss of Certain Protein Is Associated With Poor Prognosis in Breast, Lung Cancer

TAMPA, Fla. (Jan. 30, 2014) – Moffitt Cancer Center researchers have found that breast and lung cancer patients who have low levels of a protein called tristetraprolin (TTP) have more aggressive tumors and a poorer prognosis than those with high levels of the protein.  Their study was published in the Dec. 26 issue of PLoS OneLearn more...

Moffitt Cancer Center Researchers Discover Protein Pathway Involved in Nicotine-Induced Lung Cancer Metastasis

TAMPA, Fla(Jan. 28, 2014) – Smoking is the leading cause of lung cancer, and it is estimated that more than 159,000 people in the United States died from the disease last year. Most of these deaths were because the cancer had spread to other organ sites. Following their recent discovery of a protein pathway, Moffitt Cancer Center researchers are one step closer to understanding how lung cancer cells metastasize. Learn more...

 

Moffitt Cancer Center Researchers Develop Novel Approach to Visualize, Measure Protein Complexes in Tumors

TAMPA, Fla(Jan. 14, 2014) – Cancer diagnosis and treatment decisions are often hampered by a lack of knowledge of the biological processes occurring within the tumor.  Moffitt Cancer Center researchers have developed a new approach to analyze these processes with a technique called proximity ligation assays (PLA).  PLA allows specific protein complexes to be visualized and measured in cancer specimens.  This may aid in patient treatment decisions in the future. Learn more...


 
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions